Domperidone Prices June 2023
Product
|
Category |
Region |
Price |
Domperidone |
Chemical |
China |
104,792 USD/MT |
In the second quarter of 2023, the price of the domperidone in China reached 104,792 USD/MT by June.
Domperidone Price Trend, Market Analysis, and News
IMARC’s newly published report, titled “Domperidone Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data,” offers an in-depth analysis of domperidone pricing, covering an analysis of global and regional market trends and the critical factors driving these price movements.
It encompasses an in-depth review of spot price of domperidone at major ports, a breakdown of prices including Ex Works, FOB, and CIF, alongside a region-wise dissection of domperidone price trend across North America, Europe, Asia Pacific, Latin America, the Middle East and Africa.
The report examines the elements influencing domperidone price fluctuations, such as changes in raw material costs, supply-demand dynamics, geopolitical factors, and industry-specific developments. Additionally, it integrates the latest market news, providing stakeholders with up-to-date information on market shifts, regulatory changes, and technological advancements, thereby offering a comprehensive overview that aids in strategic decision-making and forecasting.
Domperidone Market Analysis
The global domperidone market size reached US$ 613.3 Million in 2023. By 2032, IMARC Group expects the market to reach US$ 880.5 Million, at a projected CAGR of 4.10% during 2023-2032.
- The increasing cases of gastrointestinal conditions, including gastritis, gastroesophageal reflux disease (GERD), and gastroparesis are significantly influencing the demand for domperidone. These conditions often cause vomiting and nausea, which domperidone effectively manages. According to an article published by the Hindustan Times, Gastroesophageal Reflux Disease or GERD is one of the most common digestive diseases in India, around 20-30% of the population is said to suffer from this condition. Over the last decade, there has been a significant increase in the proportion of younger patients especially those within the age range of 30-39 years, who have come to us with GERD.
- The growing aging population is more prone to chronic illnesses and digestive disorders which is leading to increased use of domperidone. Elderly patients often experience lower gastric emptying and other gastrointestinal issues, making domperidone a crucial part of their treatment regimen. According to the report by the United Nations Population Fund and the International Institute for Population Sciences, there were 149 million persons aged 60 years and above in 2022 (as of July), comprising around 10.5% of the country's population. And, by 2015, this population will double to 20.8%, with the absolute number at 347 million. By the end of the century, the elderly will constitute over 36% of the total population of the country.
- Cancer patients undergoing chemotherapy frequently suffer from vomiting and nausea as side effects. The extensive use of domperidone to alleviate these symptoms is supporting the growth of the market. Advances in cancer treatment protocols incorporating supportive care medications also enhance the demand for domperidone. According to NIH, cancer is among the leading causes of death worldwide. In 2022, there were almost 20 million new cases and 9.7 million cancer-related deaths worldwide. By, 2040, the number of new cancer cases per year is expected to rise to 29.9 million and the number of cancer-related deaths to 15.3 million.
Domperidone News
The report covers the latest developments, updates, and trends impacting the global domperidone market, providing stakeholders with timely and relevant information. This segment covers a wide array of news items, including the inauguration of new production facilities, advancements in domperidone production technologies, strategic market expansions by key industry players, and significant mergers and acquisitions that impact the domperidone price trend.
Latest developments in the domperidone industry:
- In March 2024, Bon Secours Maryview Medical Center unveiled a new addition to its medical services with the introduction of the LINX Reflux Management System to treat gastroesophageal reflux disease (GERD).
- In November 2023, Phanthom Pharmaceuticals Inc., a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, announced that the US Food and Drug Administration (FDA) has approved VOQUENZA (vonoprazan) tablets 10 mg and 20 mg, a novel potassium-competitive acid blocker (PCAB), as a new treatment for adults for the healing of all grades of Erosive Esophagitis, also known as Erosive GERD (gastroesophageal reflux disease), maintenance of healing of all grades of Erosive GERD, and relief of heartburn associated with Erosive Gerd.
Product Description
Domperidone refers to medication that majorly acts as a dopamine antagonist. It is employed to treat nausea and vomiting caused by different conditions, such as gastroenteritis, chemotherapy, and Parkinson’s disease. Domperidone works by blocking dopamine receptors in the gastrointestinal tract and the chemoreceptor trigger zone, which helps to alleviate nausea and vomiting. It enhances gastrointestinal motility, making it useful in treating gastroparesis and other digestive disorders where delayed stomach emptying is an issue. It is available in several forms, such as tablets, suspensions, and suppositories. It is generally well tolerated, but potential side effects such as dry mouth, abdominal cramps, and less commonly, cardiovascular effects such as arrhythmias. The use of domperidone is often regulated and monitored due to these risks. Patients need to follow their healthcare provider’s instructions and discuss any existing health conditions or medications to avoid adverse interactions.
Regional Coverage
The report provides a detailed analysis of the domperidone market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of ex-works, FOB, and CIF prices, as well as the key factors influencing the domperidone price trend.
Global Domperidone Price
The report offers a holistic view of the global domperidone pricing trends in the form of domperidone price charts, reflecting the worldwide interplay of supply-demand balances, international trade policies, and overarching economic factors that shape the market on a macro level. This comprehensive analysis not only highlights current price of domperidone but also provides insights into historical price trends, enabling stakeholders to understand past fluctuations and their underlying causes.
The report also delves into price forecast models, projecting future price movements based on a variety of indicators such as expected changes in supply chain dynamics, anticipated policy shifts, and emerging market trends. By examining these factors, the report equips industry participants with the necessary tools to make informed strategic decisions, manage risks, and capitalize on market opportunities. Furthermore, it includes a detailed domperidone demand analysis, breaking down regional variations and identifying key drivers specific to each geographic market, thus offering a nuanced understanding of the global pricing landscape.
Europe Domperidone Price
European domperidone prices are examined, highlighting the market-specific influences in the region, such as stringent environmental regulations, the competitive landscape, and import-export imbalances that significantly affect pricing structures.
This analysis can be extended to include detailed domperidone price information for a comprehensive list of countries.
Region |
Countries Covered |
Europe |
Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal, and Greece, among other European countries. |
North America Domperidone Price
The analysis of domperidone prices in North America delves into the regional industry dynamics, encompassing the impact of local production capacities and the trade flows between North America and other significant global markets.
Specific domperidone historical data within the United States and Canada can also be provided.
Region |
Countries Covered |
North America |
United States and Canada |
Middle East and Africa Domperidone Price
The report explores the domperidone pricing trends in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.
In addition to region-wise data, information on domperidone prices for countries can also be provided.
Region |
Countries Covered |
Middle East & Africa |
Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco, among other Middle Eastern and African countries. |
Asia Pacific Domperidone Price
The domperidone pricing trends in Asia Pacific are examined, reflecting the role of the region as a major global production hub and consumer market, with price dynamics heavily influenced by supply chain efficiencies, regional demand surges, and policy shifts in major economies.
This domperidone price analysis can be expanded to include a comprehensive list of countries within the region.
Region |
Countries Covered |
Asia Pacific |
China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand, among other Asian countries. |
Latin America Domperidone Price
The analysis of domperidone prices in Latin America provides a detailed overview, reflecting the unique market dynamics in the region influenced by economic policies, industrial growth, and trade frameworks.
This comprehensive review can be extended to include specific countries within the region.
Region |
Countries Covered |
Latin America |
Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru, among other Latin American countries. |
Report Coverage
Key Attributes |
Details |
Product Name |
Domperidone |
Report Features |
Exploration of Historical Trends and Market Outlook, Industry Demand, Industry Supply, Gap Analysis, Challenges, Domperidone Price Analysis, and Segment-Wise Assessment. |
Currency/Units |
US$ (Data can also be provided in local currency) or Metric Tons |
Region/Countries Covered |
The current coverage includes analysis at the global and regional levels only.
Based on your requirements, we can also customize the report and provide specific information for the following countries:
Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand*
Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece*
North America: United States and Canada
Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru*
Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco*
*The list of countries presented is not exhaustive. Information on additional countries can be provided if required by the client. |
Information Covered for Key Suppliers |
- Company Overview
- Business Description
- Product Portfolio
- Recent Trends and Developments
|
Customization Scope |
The report can be customized as per the requirements of the customer |
Report Price and Purchase Option |
Plan A: Monthly Updates - Annual Subscription
- Scope
- Historical Data for the Current Month
- Forecast for Next Month
- Total Deliverables Per Year: 12 (One Per Month)
- Includes: One PDF and Excel datasheet per month, Post Purchase Analyst Support throughout the year
Plan B: Quarterly Updates - Annual Subscription
- Scope
- Historical Data for the Current Quarter
- Forecast for Next Quarter
- Total Deliverables Per Year: 4 (One Per Quarter)
- Includes: One PDF and Excel datasheet per Quarter, Post Purchase Analyst Support throughout the year
Plan C: Biannually Updates - Annual Subscription
- Scope
- Historical Data for the Current Half
- Forecast for the Next Half
- Total Deliverables Per Year: 2 (One Per 6 Months)
- Includes: One PDF and Excel datasheet per Half, Post Purchase Analyst Support throughout the year
|
Post-Sale Analyst Support |
360-degree analyst support after report delivery |
Delivery Format |
PDF and Excel through email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Benefits for Stakeholders:
- IMARC’s report presents a detailed analysis of domperidone pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
- The study examines factors affecting domperidone price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
- The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
- IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The domperidone price charts ensure our clients remain at the forefront of the industry.